An anonymous director reports

ELSE NUTRITION TO REPORT FIRST QUARTER 2023 FINANCIAL RESULTS ON MAY 15, 2023

Else Nutrition Holdings Inc. expects to release its first quarter 2023 financial results for the period ending March 31, 2023, on May 15, 2023. The company has scheduled a conference call on the same day, at 10 a.m. ET, to discuss the results.

Interested parties can access the conference call via Internet webcast, which is available in the investors section of the company's website. Interested parties who would like to submit a question to be addressed on the call should e-mail the question to shamsian@lythampartners.com.

A webcast replay will be available in the investors section of the company's website.

About Else Nutrition Holdings Inc.

Else Nutrition is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the 2017 best health and diet solutions award at the Global Food Innovation Summit in Milan. Else plant-based complete nutrition for toddlers was recently ranked as the No. 1 top seller in the baby and toddler formula category on Amazon. The company recently received the World Plant-Based Award for best dairy alternative product in New York at World Plant-Based Expo in late 2021. The holding company, Else Nutrition Holdings, is a publicly traded company, listed on the Toronto Stock Exchange under the trading symbol BABY and quoted on the U.S. OTCQX Market under the trading symbol BABYF and on the Frankfurt Stock Exchange under the symbol 0YL. Else's executives include leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centres and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, United States; Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel; and University Hospital Brussels, Belgium.

We seek Safe Harbor.